The Full Precrime Analysis

Precrime: Structural-Metadata Screening of Pre-Financial Securities Issuers on EDGAR — working paper (draft), M.P., June 2026.

Read the full draft inline, page by page, or open it larger — or listen to the paper read aloud: the player opens the PDF beside a word-synced narration with the floating cane head.

Play narration 34:17

Each entity is scored purely from its EDGAR submission record — form types, cadence, agents, name history — no narrative input. Each heuristic that fires casts a weighted vote:

score(e) = Σh∈H wh · 𝟙[ h fires on e ]      wh ∈ {2, 3}
flag(e)  = 1   ⟺   nsig(e) ≥ 2   ∧   score(e) ≥ τ   (τ = 3)

A lone signal is never flagged (nsig ≥ 2 required). Maximum score is 38. Tiers set review cadence: T1 ≥ 10 (daily), T2 6–9 (weekly), T3 3–5 (quarterly). On the model's validation set it fired a mean of 6.6 years before any public action; the same heuristics would have surfaced LATI as early as 1996 and Davi Skin by 2004 — years ahead of the 2007–08 dump. No enforcement has ever followed against either.

What the sixteen heuristics flag — ●●● high weight, ●● moderate:

Transformation. name-recycling ●●● flags a corporate name reused across CIKs, or repeated renames on one CIK — a shell wearing new names to outrun its history. shell-reactivation ●●● catches a dark entity that stops then resumes filing — a parked shell brought back to host a deal. reverse-merger chain ●●● is the 8-K Item 5.06 → 2.01 → 5.03 sequence, a private company taking a public listing without an IPO. SIC drift ●● fires when the industry code shifts to a business the assets do not support.

Issuance & legend removal. penny-stock S-1/S-8 ●● and Form D-only issuer ●●● flag share registrations and private placements that raise capital with little public reporting. Reg S ●● and Reg A ●● are offerings placed with foreign or small investors. promissory clauses ●● catch the convertible notes that become the debt-to-equity lever. opinion letter ●●● flags an attorney's letter of counsel — the key that removes a restrictive legend. Form 144 outlier ●● and self-filer for material capital ●● mark restricted-stock sales and material events handled in-house rather than by independent counsel.

Reporting behaviour. late-filer cluster ●● flags a run of NT (late-filing) notices; going-dark blackout ●● fires when the EDGAR record falls silent while the stock keeps trading.

Relationships & the regulator. filer-agent overlap ●●● flags one EDGAR filing agent preparing filings for multiple, ostensibly unrelated issuers; SEC staff action ●●● fires on comment letters or UPLOAD correspondence — the regulator already raised a hand.

Reconstructed from the case findings — each cell marks a signal that entity's filings trip. Official structural totals: Davi Skin 28 / 38 (12 signals · Tier 1) and LATI ≥ 24 / 38 (10 signals · Tier 1).

Lineage A · CIK 878146: Tele-Lawyer → (rename 18 Nov 1996) Dynamic Associates → (rename 15 May 2001) Legal Access Technologies (LGAL) → goes dark, last filing 30 Aug 2006.

Lineage B · CIK 1059577: MW Medical (1998) → (8-K 5.06→2.01→5.03, 24 Jun 2004) Davi Skin (DAVN, SIC 2844) → registration REVOKED 27 Aug 2012.

Common control thread: CIK 0001144030 = Kyleen E. Cane (individual), who filed the SC 13D on LATI through the same agent (0001255294) that prepared the Davi Skin / MW Medical filings — until Davi switched agents at the 2007 dump.

Tier 1 · score ≥ 24 / 38 · ten-plus distinct signals · earliest trip 18 Nov 1996 (first rename).

Three corporate names on one CIK; two formerNames renames; a Schedule 13D by Kyleen/Michael Cane (CIK 0001144030) through the shared agent; a $140k convertible note at $0.07/sh (8-K, 10 Dec 2004); an S-8 with an EX-4 counsel opinion (5 Jul 2001). The EDGAR record goes dark in 2006 while LGAL continued OTC trading through 2010 — 61 volume dislocations, 0 contemporaneous control events to bind to: the going-dark + shell-reactivation fingerprint.

Tier 1 · score 28 / 38 · twelve distinct signals · earliest trip 24 Jun 2004 (reverse merger / name change).

The textbook 8-K Items 5.06→2.01→5.03 reverse-merger sequence; a SIC pivot from medical devices to cosmetics (2844); the filer-agent overlap with LATI and the Cane 13Ds; a late-filer cluster (NT 10-Q ×23, NT 10-K ×10); a Reg S issuance to four foreign investors that drew SEC comment letters and an eventual REVOKED status; an S-8 + EX-5.1 opinion of counsel; and Wallace's $570,775.30 convertible note. In the Jan–Nov 2008 window the price/volume model flagged 11 dislocations, 1 confirmed.

open the day-by-day price & volume chart

Read in sequence, a handful of accessions map the whole scheme — each one a flag in its own right:

The Davi Skin name change opens with an 8-K (Acc. 0001255294-04-000201, 24 Jun 2004) carrying the EX-2.1 merger agreement and the textbook Items 5.06 → 2.01 → 5.03 sequence — the reverse-merger fingerprint. Weeks later an SC 14F1 (0001255294-04-000214, 20 Jul 2004) changes control without a shareholder vote and books Wallace's $570,775.30 convertible note. An S-8 with an EX-5.1 opinion of counsel (0001255294-04-000267, 15 Sep 2004) is the legend-removal mechanism — the attorney certifying that her own restricted shares may trade.

A 10-QSB Reg S (0001255294-05-000310, 23 May 2005) issues units to four foreign investors; the regulator notices, and a SEC staff comment letter (0000000000-05-042920, Aug 2005) challenges it. An SB-2 resale registration (0001255294-06-000321, 12 May 2006) lines insider shares up for public resale. Then the tell: the FY2006 10-KSB (0001117768-07-000030, 2007) is filed by a new agent — the filing-agent switch that coincides with the dump.

On the LATI side the same shape recurs: an S-8 + EX-4 opinion (0001075793-01-500109, 5 Jul 2001) and a $140k convertible-note 8-K (0001255294-04-000348, 10 Dec 2004).